A carregar...
Outcomes Following ATG Therapy for Chronic Lung Allograft Dysfunction
Chronic lung allograft dysfunction (CLAD) is the major factor limiting survival post lung transplantation (LTx) with limited effective therapeutic options. We report our 12-y experience of antithymocyte globulin (ATG) as second-line CLAD therapy. METHODS. Clinical and lung function data were collect...
Na minha lista:
| Publicado no: | Transplant Direct |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7969305/ https://ncbi.nlm.nih.gov/pubmed/33748410 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000001134 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|